Grifols (GRFS) Change in Taxes (2010)
Grifols (GRFS) posted Change in Taxes of $5.7 million for Q1 2013, up 175620.15% quarter-over-quarter from -$3273.0 in Q1 2012, and up 175620.15% year-on-year from N/an in Q1 2012.
Grifols (GRFS) Change in Taxes (2010) Analysis & Trends
Grifols (GRFS) has reported Change in Taxes for 3 consecutive years, with $5.7 million the latest figure, recorded in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -81.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -526.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 71.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | -29.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2010 | -3.12 Mn |
| Sep 30, 2010 | -3.12 Mn |